Contraindicated in:
Use Cautiously in:
Noted for concurrent use with insulin
Derm: local allergy.
Endo: HYPOGLYCEMIA.
GI: nausea, abdominal pain, anorexia, vomiting.
MS: arthralgia.
Neuro: dizziness, fatigue, headache.
Resp: cough.
Misc: injection site reactions, systemic allergic reactions.
Drug-Drug:
Insulin-using Type 2 Diabetes
Type 1 Diabetes
Absorption: 3040% absorbed following SUBQ administration.
Distribution: Does not appear to significantly cross the placenta.
Metabolism/Excretion: Metabolized by the kidneys; major metabolite has pharmacologic properties similar to the parent compound.
Half-life: 48 min.
NDC Code*